CERO

CERO

USD

CERo Therapeutics Holdings Inc. Common Stock

$8.560-0.260 (-2.948%)

Real-time Price

Healthcare
Biotechnology
United States

Price Chart

Loading Chart...

Key Metrics

Market Metrics
Company Fundamentals
Trading Stats

Market Metrics

Open

$8.820

High

$8.830

Low

$8.400

Volume

0.04M

Company Fundamentals

Market Cap

4.4M

Industry

Biotechnology

Country

United States

Trading Stats

Avg Volume

1.19M

Exchange

NCM

Currency

USD

52-Week Range

Low $6.71Current $8.560High $896

Related News

Analyst Upgrades

D. Boral Capital Maintains Buy on CERo Therapeutics Hldgs, Maintains $30 Price Target

D. Boral Capital analyst Jason Kolbert maintains CERo Therapeutics Hldgs with a Buy and maintains $30 price target.

View more
D. Boral Capital Maintains Buy on CERo Therapeutics Hldgs, Maintains $30 Price Target
Analyst Upgrades

D. Boral Capital Upgrades CERo Therapeutics Hldgs to Buy, Announces $30 Price Target

D. Boral Capital analyst Jason Kolbert upgrades CERo Therapeutics Hldgs from Hold to Buy and announces $30 price target.

View more
D. Boral Capital Upgrades CERo Therapeutics Hldgs to Buy, Announces $30 Price Target
GlobeNewswire

CERo Therapeutics Holdings, Inc. Announces Reverse Stock Split

SOUTH SAN FRANSCISCO, Calif., June 11, 2025 (GLOBE NEWSWIRE) -- CERo Therapeutics Holdings, Inc., (NASDAQ:CERO) ("CERo" or the "Company") an innovative immunotherapy company seeking to advance the next generation of

View more
CERo Therapeutics Holdings, Inc. Announces Reverse Stock Split
GlobeNewswire

CERo Therapeutics, Inc. Announces Option Exercise for Additional Series D Financing

SOUTH SAN FRANCISCO, Calif., June 06, 2025 (GLOBE NEWSWIRE) -- CERo Therapeutics Holdings, Inc. (NASDAQ:CERO) ("CERo"), an innovative immunotherapy company seeking to advance the next generation of engineered T cell

View more
CERo Therapeutics, Inc. Announces Option Exercise for Additional Series D Financing

Stay Updated

Set price alerts, get AI analysis updates and real-time market news.